Literature DB >> 18805742

Anti-shock garment in postpartum haemorrhage.

Suellen Miller1, Hilarie B Martin, Jessica L Morris.   

Abstract

The non-pneumatic anti-shock garment (NASG) is a first-aid device that reverses hypovolaemic shock and decreases obstetric haemorrhage. It consists of articulated neoprene segments that close tightly with Velcro, shunting blood from the lower body to the core organs, elevating blood pressure and increasing preload and cardiac output. This chapter describes the controversial history of the predecessors of NASG, pneumatic anti-shock garments (PASGs), relates case studies of PASG for obstetric haemorrhage, compares pneumatic and non-pneumatic devices and posits why the NASG is more appropriate for low-resource settings. This chapter discusses the only evidence available about NASGs for obstetric haemorrhage - two pre-post pilot trials and three case series - and describes recently initiated randomized cluster trials in Africa. Instructions and an algorithm for ASGs in haemorrhage and shock management are included. Much remains unknown about the NASG, a promising intervention for obstetric haemorrhage management.

Entities:  

Mesh:

Year:  2008        PMID: 18805742     DOI: 10.1016/j.bpobgyn.2008.08.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  7 in total

1.  Positive effects of the non-pneumatic anti-shock garment on delays in accessing care for postpartum and postabortion hemorrhage in Egypt and Nigeria.

Authors:  Janet Turan; Oladosu Ojengbede; Mohamed Fathalla; Mohammed Mourad-Youssif; Imran O Morhason-Bello; David Nsima; Jessica Morris; Elizabeth Butrick; Hilarie Martin; Carol Camlin; Suellen Miller
Journal:  J Womens Health (Larchmt)       Date:  2010-12-29       Impact factor: 2.681

2.  FIGO recommendations on the management of postpartum hemorrhage 2022.

Authors:  Maria Fernanda Escobar; Anwar H Nassar; Gerhard Theron; Eythan R Barnea; Wanda Nicholson; Diana Ramasauskaite; Isabel Lloyd; Edwin Chandraharan; Suellen Miller; Thomas Burke; Gabriel Ossanan; Javier Andres Carvajal; Isabella Ramos; Maria Antonia Hincapie; Sara Loaiza; Daniela Nasner
Journal:  Int J Gynaecol Obstet       Date:  2022-03       Impact factor: 4.447

3.  Obstetric hemorrhage and shock management: using the low technology Non-pneumatic Anti-Shock Garment in Nigerian and Egyptian tertiary care facilities.

Authors:  Suellen Miller; Mohamed M F Fathalla; Oladosu A Ojengbede; Carol Camlin; Mohammed Mourad-Youssif; Imran O Morhason-Bello; Hadiza Galadanci; David Nsima; Elizabeth Butrick; Tarek Al Hussaini; Janet Turan; Carinne Meyer; Hilarie Martin; Aminu I Mohammed
Journal:  BMC Pregnancy Childbirth       Date:  2010-10-18       Impact factor: 3.007

4.  Can the Non-pneumatic Anti-Shock Garment (NASG) reduce adverse maternal outcomes from postpartum hemorrhage? Evidence from Egypt and Nigeria.

Authors:  Mohammed Mourad-Youssif; Oladosu A Ojengbede; Carinne D Meyer; Mohammad Fathalla; Imran O Morhason-Bello; Hadiza Galadanci; Carol Camlin; David Nsima; Tarek Al Hussaini; Elizabeth Butrick; Suellen Miller
Journal:  Reprod Health       Date:  2010-09-01       Impact factor: 3.223

5.  Nonpneumatic antishock garment combined with bakri balloon as a nonoperative "uterine sandwich" for temporization of massive postpartum hemorrhage from disseminated intravascular coagulation.

Authors:  Andrea Jelks; Monica Berletti; Liliana Hamlett; Michele Hugin
Journal:  Case Rep Obstet Gynecol       Date:  2015-01-08

6.  Hemodynamic response to non-pneumatic anti-shock compression garments in patients with renal dysfunction.

Authors:  R Marinovich; Z Li; T Tamasi; K Quinn; S Wong; C W McIntyre
Journal:  BMC Nephrol       Date:  2020-01-14       Impact factor: 2.388

7.  Utilization of non-pneumatic anti-shock garment and associated factors for postpartum hemorrhage management among health care professionals' in public hospitals of Jimma zone, south-West Ethiopia, 2019.

Authors:  Gadisa Bekele; Gemechu Terefe; Makeda Sinaga; Sena Belina
Journal:  Reprod Health       Date:  2020-03-17       Impact factor: 3.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.